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Pleuropulmonary blastoma is a rare aggressive 
malignant tumor of infancy and early childhood. The 
tumor arises in the lung and pleura and is regarded as a 
pulmonary dysontogenetic or embryonic neoplasm. It is 
the pulmonary analog of other tumors of childhood 
including Wilms' tumor, neuroblastoma, 
hepatoblastoma, pancreatoblastoma, and 
retinoblastoma. 
Synonyms include embryonal rhabomyosarcoma 
arising in congenital bronchogenic cyst, 
rhabdomyosarcoma arising in congenital cystic 
adenomatoid malformation, pulmonary sarcoma  
arising in mesenchymal cystic hamartoma, pulmonary 
blastoma associated with cystic lung disease of 
childhood. 
Clinics and pathology 
Epidemiology 
There are over 120 cases registered with The 
Pleuropulmonary Blastoma Registry 
(www.ppbregistry.org). The tumor affects mainly in 
children with age ranges from 1 month to 12 years. 
Most cases are diagnosed before 4 years of age. It can 
be found prenatally or present in older children and 
young adults. Males and females are equally affected. 
 
(A) Type I pleuropulmonary blastoma consists of multiloculated cyst filled with scanty clear serous fluid. (B) The cysts are lined by 
cuboidal epithelium resting on loose mesenchymal tissue. 
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(C) There are areas of proliferating primitive cells with overlying stratified ciliated columnar epithelium. (D) Foci of rhabdomyoblasts with 
abundant eosinophilic cytoplasm and cross striations are noted. 
 
Clinics 
Approximately 25% of cases are associated with a 
heritable tumor syndrome. Additional tumors including 
cystic nephromas and other nephroblastic lesions, 
ovarian teratomas, multiple intestinal polyps, thyroid 
malignancies, medulloblastomas, and second 
pleuropulmonary blastomas have been observed in 
affected children. Clinical manifestations vary and 
depend on age and pathologic type of tumors. Most 
patients are presented with respiratory symptoms 
including dyspnea, chest pain, cough, and respiratory 
distress with or without pneumothorax. Asymptomatic 
lesions may be detected incidentally during 
investigation of unrelated clinical problems. 
Pathology 
There are 3 pathologic types of pleuropulmonary 
blastoma with distinct macroscopic and microscopic 
features. 
Type I pleuropulmonary blastoma is characterized by 
peripherally located, multicystic, and thin-walled 
structure. No solid nodules are observed within the 
thin-walled septae and multicystic spaces. Neoplastic 
cells can be identified beneath a benign cyst lining 
surface epithelium. This "cambium layer-like" zone 
contains proliferating primitive cells with mixed small, 
rounded, or spindled hyperchromatic nuclei. 
Rhabdomyoblasts are seen occasionally. Some tumors 
have immature cartilage within their fibrous septae. 
Type II pleuropulmonary blastoma is a mixed solid an  
cystic tumor characterized by varied amount of 
thickened or nodule-like areas composed of 
rhabdomyosarcomatous or blastematous components. 
Type III pleuropulmonary blastoma is characterized by 
a well-circumscribed, mucoid, white-tan solid mass 
attached to the pleura and involves a lobe or entire 
lung. Necrosis and hemorrhage are sometimes present 
in the friable areas. Histopathologically, type III tumor 
is an apparently heterogeneous tumor composed of one 
or more of the following elements: primitive "blastema-
like" small cells with hyperchromatic nuclei with hig  
nuclear-to-cytoplasmic ratio and abundant mitoses; 
 
(A) Pleuropulmonary blastoma is composed of compact zones with primitive blastematous cells embedded in a loose myxoid stroma. (B) 
Electron microscopy shows spindle primitive cells with high nuclear-to-cytoplasmic ratio and oval nuclei. 
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Immunohistochemical stains show strong positivity with vimentin, desmin, CD117, p53, and focal positivity with alpha-1-antitrypsin in the 
primitive tumor cells. The Ki-67 reveals high proliferative index of approximately 90%. 
 
spindled and ovoid cells embedded in a myxoid stroma; 
spindle cell sarcoma; nodules of immature or malignnt 
chondroid elements. Isolated or clusters of large 
anaplastic cells with pleomorphic nuclei, atypical 
mitotic figures, or eosinophilic hyaline bodies are 
present. 
Immunohistochemically, the neoplastic cells are stained 
positive for vimentin. CD117 (c-kit) and alpha-1-
antitrypsin are focally positive in tumor cells. CD99 is 
weakly positive. Other immunostains including EMA, 
myogenin, S100, GFAP, neuron specific enolase, TTF-
1, alpha-fetoprotein, chromogranin, and synaptophysin 
are negative. The pneumocytes lining the cysts and 
small airspaces are highlighted by cytokeratin. Muscle 
specific actin and desmin are expressed in 
rhabdomyoblasts and primitive cells in the subepithelial 
regions of cystic lesions. 
Cytogenetics 
Gains of chromosome 8 detected by karyotyping and 
fluorescence in situ hybridization is the most consistent 
recurrent chromosomal aberration. Trisomy 2,  
unbalanced translocation between chromosomes 1 and 
X, and p53 mutations/deletions have been reported. 
One case with brain metastasis reveals an abnormal 
karyotype of 44,XY,del(1)(p12),-
14der(19)add(19)(q13.3),-20. Heterozygous germline 
mutations in DICER1 are found in pleuropulmonary 
blastoma families. 
Treatment 
The current treatment for type I pleuropulmonary 
blastoma is complete surgical excision followed by 
combination chemotherapy with vincristine, 
actinomycin-D, and cyclophosphamide. Complete 
excision and adjuvant multi-agent chemotherapy are 
also applied for type II and type III tumors. Tumor 
progression from type I to type III has been 
documented. 
Prognosis 
Type I pleuropulmonary blastoma has the most 
favorable prognosis with a 5-year survival rate of 83%, 
whereas type II and III have a worse outcome of less
than 50%. 
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